Minireview: Miromics in Endocrinology: A novel approach for modeling endocrine diseases

Péter M. Szabó, Henriett Butz, P. Igaz, K. Rácz, L. Hunyady, A. Patócs

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) are small (16-24 nucleotides) noncoding RNAs that negatively regulate gene expression. Growing evidence demonstrates that miRNAs participate in the regulation of numerous physiological and pathological processes. The clinical utility of the cell-type-specific miRNA expression profile (miRomics) has been directly demonstrated in molecular classification of tumor samples and in prediction of prognosis or therapeutic responsiveness. Identification of the relevant miRNAs and their targets requires both in silico and molecular biological methods. In this review, we summarize the methodological arsenal used in miRNA-related research, and through our own data on adrenal tumors, we present how miRNA could be integrated into omics-based networks. The expanding knowledge obtained from miRNA research may lead to the development of novel diagnostic and treatment modalities in future.

Original languageEnglish
Pages (from-to)573-585
Number of pages13
JournalMolecular Endocrinology
Volume27
Issue number4
DOIs
Publication statusPublished - Apr 1 2013

Fingerprint

Endocrine System Diseases
Endocrinology
MicroRNAs
Physiological Phenomena
Untranslated RNA
Glandular and Epithelial Neoplasms
Pathologic Processes
Research
Computer Simulation
Nucleotides
Gene Expression

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this

Minireview : Miromics in Endocrinology: A novel approach for modeling endocrine diseases. / Szabó, Péter M.; Butz, Henriett; Igaz, P.; Rácz, K.; Hunyady, L.; Patócs, A.

In: Molecular Endocrinology, Vol. 27, No. 4, 01.04.2013, p. 573-585.

Research output: Contribution to journalArticle

@article{62e4f9dbfbce4f41a39777b5006e496d,
title = "Minireview: Miromics in Endocrinology: A novel approach for modeling endocrine diseases",
abstract = "MicroRNAs (miRNAs) are small (16-24 nucleotides) noncoding RNAs that negatively regulate gene expression. Growing evidence demonstrates that miRNAs participate in the regulation of numerous physiological and pathological processes. The clinical utility of the cell-type-specific miRNA expression profile (miRomics) has been directly demonstrated in molecular classification of tumor samples and in prediction of prognosis or therapeutic responsiveness. Identification of the relevant miRNAs and their targets requires both in silico and molecular biological methods. In this review, we summarize the methodological arsenal used in miRNA-related research, and through our own data on adrenal tumors, we present how miRNA could be integrated into omics-based networks. The expanding knowledge obtained from miRNA research may lead to the development of novel diagnostic and treatment modalities in future.",
author = "Szab{\'o}, {P{\'e}ter M.} and Henriett Butz and P. Igaz and K. R{\'a}cz and L. Hunyady and A. Pat{\'o}cs",
year = "2013",
month = "4",
day = "1",
doi = "10.1210/me.2012-1220",
language = "English",
volume = "27",
pages = "573--585",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Minireview

T2 - Miromics in Endocrinology: A novel approach for modeling endocrine diseases

AU - Szabó, Péter M.

AU - Butz, Henriett

AU - Igaz, P.

AU - Rácz, K.

AU - Hunyady, L.

AU - Patócs, A.

PY - 2013/4/1

Y1 - 2013/4/1

N2 - MicroRNAs (miRNAs) are small (16-24 nucleotides) noncoding RNAs that negatively regulate gene expression. Growing evidence demonstrates that miRNAs participate in the regulation of numerous physiological and pathological processes. The clinical utility of the cell-type-specific miRNA expression profile (miRomics) has been directly demonstrated in molecular classification of tumor samples and in prediction of prognosis or therapeutic responsiveness. Identification of the relevant miRNAs and their targets requires both in silico and molecular biological methods. In this review, we summarize the methodological arsenal used in miRNA-related research, and through our own data on adrenal tumors, we present how miRNA could be integrated into omics-based networks. The expanding knowledge obtained from miRNA research may lead to the development of novel diagnostic and treatment modalities in future.

AB - MicroRNAs (miRNAs) are small (16-24 nucleotides) noncoding RNAs that negatively regulate gene expression. Growing evidence demonstrates that miRNAs participate in the regulation of numerous physiological and pathological processes. The clinical utility of the cell-type-specific miRNA expression profile (miRomics) has been directly demonstrated in molecular classification of tumor samples and in prediction of prognosis or therapeutic responsiveness. Identification of the relevant miRNAs and their targets requires both in silico and molecular biological methods. In this review, we summarize the methodological arsenal used in miRNA-related research, and through our own data on adrenal tumors, we present how miRNA could be integrated into omics-based networks. The expanding knowledge obtained from miRNA research may lead to the development of novel diagnostic and treatment modalities in future.

UR - http://www.scopus.com/inward/record.url?scp=84875493856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875493856&partnerID=8YFLogxK

U2 - 10.1210/me.2012-1220

DO - 10.1210/me.2012-1220

M3 - Article

C2 - 23349525

AN - SCOPUS:84875493856

VL - 27

SP - 573

EP - 585

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 4

ER -